Valuation: Photocure ASA

Market Cap 156.45Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.52TCr 23Cr 153.47Cr 60Cr 744.72Cr 60Cr 58Cr 2.57TCr P/E 2026 *
17.1x
P/E 2027 * 34.9x
Enterprise Value 132.25Cr 13Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 129.73Cr 50Cr 629.53Cr 50Cr 49Cr 2.17TCr EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.96x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-2.00%
Current month-0.67%
1 month+1.20%
3 months+1.38%
6 months-21.05%
Current year-17.51%
1 week 57.6
Extreme 57.6
61.4
1 month 56.2
Extreme 56.2
62.1
Current year 55.2
Extreme 55.2
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/25/02BuyCompany 11,355 0.0419%
02/25/02BuyCompany 8,997 0.0332%
31/25/31BuyCompany 21,105 0.0778%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-2.00%+6.32%+20.70% 16Cr
-1.02%+0.48%+55.50%+160.66% 1,08200Cr
-1.80%+3.29%+68.60%+61.56% 63TCr
-0.93%+3.05%+37.93%+89.70% 46TCr
-2.70%+1.37%+31.00%+23.05% 34TCr
-2.39%-0.56%+39.15%+37.66% 30TCr
-1.45%+0.57%+30.03%+44.77% 29TCr
-1.89%+2.81%-26.62%-40.17% 22TCr
-1.29%+4.41%+25.45%+65.64% 20TCr
+0.14%+2.65%+17.47%+69.95% 16TCr
Average -1.24%+3.68%+28.48%+53.35% 36.93TCr
Weighted average by Cap. -1.44%+5.43%+41.72%+81.83%

Financials

2026 *2027 *
Net sales 66Cr 6.69Cr 5.85Cr 5.38Cr 5.01Cr 9.51Cr 637.21Cr 9.65Cr 65Cr 25Cr 313.22Cr 25Cr 25Cr 1.08TCr 66Cr 6.74Cr 5.89Cr 5.42Cr 5.05Cr 9.58Cr 642.05Cr 9.72Cr 65Cr 25Cr 315.6Cr 25Cr 25Cr 1.09TCr
Net income 9.23Cr 93.91L 82.1L 75.45L 70.32L 1.33Cr 89Cr 1.35Cr 9.06Cr 3.52Cr 44Cr 3.53Cr 3.45Cr 151.46Cr 4.5Cr 45.77L 40.01L 36.77L 34.27L 65.01L 44Cr 65.99L 4.41Cr 1.72Cr 21Cr 1.72Cr 1.68Cr 74Cr
Net Debt -24Cr -2.46Cr -2.15Cr -1.98Cr -1.84Cr -3.5Cr -234.35Cr -3.55Cr -24Cr -9.23Cr -115.2Cr -9.24Cr -9.04Cr -396.96Cr -26Cr -2.67Cr -2.34Cr -2.15Cr -2Cr -3.79Cr -254.37Cr -3.85Cr -26Cr -10Cr -125.04Cr -10Cr -9.81Cr -430.86Cr
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
06/26/06 NOK 58.90 +0.17% 15,106
03/26/03 NOK 58.80 -0.68% 28,832
02/26/02 NOK 59.20 +1.89% 17,760
01/26/01 NOK 58.10 -2.02% 55,585
30/26/30 NOK 59.30 -1.33% 19,305
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
58.80NOK
Average target price
84.00NOK
Spread / Average Target
+42.86%

Quarterly revenue - Rate of surprise